A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification

A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification

Sepsis is a potentially life–threatening complication of infection and diagnosis depends on rapid assessment of leukocyte count and CD64 expression. Here the authors present a microfluidic chip that can quantify these parameters from minimal amounts of whole blood with no manual processing.

Bibliographic Details
Main Authors: U. Hassan, T. Ghonge, B. Reddy Jr., M. Patel, M. Rappleye, I. Taneja, A. Tanna, R. Healey, N. Manusry, Z. Price, T. Jensen, J. Berger, A. Hasnain, E. Flaugher, S. Liu, B. Davis, J. Kumar, K. White, R. Bashir
Format: Article
Language:English
Published: Nature Publishing Group 2017-07-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/ncomms15949

Internet

https://doi.org/10.1038/ncomms15949

Similar Items